Report Detail
Global Toxoid Vaccines Market Growth 2019-2024
- RnM3161124 |
- 22 March, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
According to this study, over the next five years the Toxoid Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Toxoid Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Toxoid Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the Toxoid Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals And Clinics
Government Organizations
Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Valeant Pharmaceuticals
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Toxoid Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Toxoid Vaccines market by identifying its various subsegments.
Focuses on the key global Toxoid Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Toxoid Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Toxoid Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Toxoid Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Toxoid Vaccines Consumption 2014-2024
- 2.1.2 Toxoid Vaccines Consumption CAGR by Region
- 2.2 Toxoid Vaccines Segment by Type
- 2.2.1 Monovalent Tetanus Toxoid (TT)
- 2.2.2 Diphtheria
- 2.2.3 Tetanus
- 2.2.4 Pertussis (DTaP)
- 2.2.5 Diphtheria and Tetanus (DT)
- 2.3 Toxoid Vaccines Consumption by Type
- 2.3.1 Global Toxoid Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Toxoid Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Toxoid Vaccines Sale Price by Type (2014-2019)
- 2.4 Toxoid Vaccines Segment by Application
- 2.4.1 Hospitals And Clinics
- 2.4.2 Government Organizations
- 2.4.3 Research
- 2.4.4 Others
- 2.5 Toxoid Vaccines Consumption by Application
- 2.5.1 Global Toxoid Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Toxoid Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Toxoid Vaccines Sale Price by Application (2014-2019)
3 Global Toxoid Vaccines by Players
- 3.1 Global Toxoid Vaccines Sales Market Share by Players
- 3.1.1 Global Toxoid Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Toxoid Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global Toxoid Vaccines Revenue Market Share by Players
- 3.2.1 Global Toxoid Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Toxoid Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global Toxoid Vaccines Sale Price by Players
- 3.4 Global Toxoid Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Toxoid Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Toxoid Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Toxoid Vaccines by Regions
- 4.1 Toxoid Vaccines by Regions
- 4.1.1 Global Toxoid Vaccines Consumption by Regions
- 4.1.2 Global Toxoid Vaccines Value by Regions
- 4.2 Americas Toxoid Vaccines Consumption Growth
- 4.3 APAC Toxoid Vaccines Consumption Growth
- 4.4 Europe Toxoid Vaccines Consumption Growth
- 4.5 Middle East & Africa Toxoid Vaccines Consumption Growth
5 Americas
- 5.1 Americas Toxoid Vaccines Consumption by Countries
- 5.1.1 Americas Toxoid Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Toxoid Vaccines Value by Countries (2014-2019)
- 5.2 Americas Toxoid Vaccines Consumption by Type
- 5.3 Americas Toxoid Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Toxoid Vaccines Consumption by Countries
- 6.1.1 APAC Toxoid Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Toxoid Vaccines Value by Countries (2014-2019)
- 6.2 APAC Toxoid Vaccines Consumption by Type
- 6.3 APAC Toxoid Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Toxoid Vaccines by Countries
- 7.1.1 Europe Toxoid Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Toxoid Vaccines Value by Countries (2014-2019)
- 7.2 Europe Toxoid Vaccines Consumption by Type
- 7.3 Europe Toxoid Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Toxoid Vaccines by Countries
- 8.1.1 Middle East & Africa Toxoid Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Toxoid Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Toxoid Vaccines Consumption by Type
- 8.3 Middle East & Africa Toxoid Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Toxoid Vaccines Distributors
- 10.3 Toxoid Vaccines Customer
11 Global Toxoid Vaccines Market Forecast
- 11.1 Global Toxoid Vaccines Consumption Forecast (2019-2024)
- 11.2 Global Toxoid Vaccines Forecast by Regions
- 11.2.1 Global Toxoid Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Toxoid Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Toxoid Vaccines Forecast by Type
- 11.8 Global Toxoid Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 GlaxoSmithKline
- 12.1.1 Company Details
- 12.1.2 Toxoid Vaccines Product Offered
- 12.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GlaxoSmithKline News
- 12.2 Merck
- 12.2.1 Company Details
- 12.2.2 Toxoid Vaccines Product Offered
- 12.2.3 Merck Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 Toxoid Vaccines Product Offered
- 12.3.3 Pfizer Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 Sanofi Pasteur
- 12.4.1 Company Details
- 12.4.2 Toxoid Vaccines Product Offered
- 12.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sanofi Pasteur News
- 12.5 AstraZeneca
- 12.5.1 Company Details
- 12.5.2 Toxoid Vaccines Product Offered
- 12.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 AstraZeneca News
- 12.6 Bharat Biotech
- 12.6.1 Company Details
- 12.6.2 Toxoid Vaccines Product Offered
- 12.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Bharat Biotech News
- 12.7 Shenzhen Kangtai Biological Products
- 12.7.1 Company Details
- 12.7.2 Toxoid Vaccines Product Offered
- 12.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Shenzhen Kangtai Biological Products News
- 12.8 Valeant Pharmaceuticals
- 12.8.1 Company Details
- 12.8.2 Toxoid Vaccines Product Offered
- 12.8.3 Valeant Pharmaceuticals Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Valeant Pharmaceuticals News
- 12.9 Emergent Biosolutions
- 12.9.1 Company Details
- 12.9.2 Toxoid Vaccines Product Offered
- 12.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Emergent Biosolutions News
- 12.10 Astellas Pharma
- 12.10.1 Company Details
- 12.10.2 Toxoid Vaccines Product Offered
- 12.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Astellas Pharma News
- 12.11 Panacea Biotec
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Toxoid Vaccines . Industry analysis & Market Report on Toxoid Vaccines is a syndicated market report, published as Global Toxoid Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Toxoid Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
